Previous 10 | Next 10 |
Company to Provide Updates on Phase 2 Clinical Trials for COVID-19 Vaccine and Immuno-oncology/Gedeptin® Atlanta, GA, June 07, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company specializing in developing hu...
Buying Penny Stocks on June 2nd, Here’s What You Need to Know After another less-than-stellar day of trading penny stocks and blue chips, there is a lot for investors to know. Although buying and selling penny stocks is not easy, it can be much easier than previously imagined...
The latest outbreak of monkeypox has some scratching their heads. What more can 2022 bring to the market? We’ve seen a stock market crash, the hopeful recovery from COVID-19, record inflation, rising rates, and now this. But it has placed some penny stocks in focus. On Wednes...
SIGA Technologies (NASDAQ:SIGA) is a notable decliner among companies that benefitted from a recent monkeypox outbreak on Tuesday after the World Health Organization said that rare viral disease is unlikely to cause a pandemic. More than 300 suspected and confirmed cases of monkeypox have bee...
3 Top Penny Stocks to Add to Your Watchlist Right Now After a very bullish day of trading for penny stocks and blue chips, investors are now wondering what stocks to buy moving forward. Many penny stocks have seen their values increase in the last day or two, however, we should not ...
Gainers: Apyx Medical (APYX) +39%. Enochian Biosciences (ENOB) +17%. Concert Pharmaceuticals (CNCE) +14%. GeoVax Labs (GOVX) +14%. Liquidia (LQDA) +13%. Losers: NRx Pharmaceuticals (NRXP) -57%. Avadel Pharmaceuticals (AVDL) -44%. Nurix Therape...
GeoVax Labs (GOVX) -27% has entered into a definitive agreement with an institutional investor for the issuance and sale of 3,030,304 common shares at $1.65/share (or pre-funded warrant in lieu thereof) in a registered direct offering. In a concurrent private placement, GeoVax (GOVX...
Atlanta, GA - ( NewMediaWire ) - May 25, 2022 - GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company specializing in developing human vaccines and cancer immunotherapies, announced today that it has entered into a definitive agreement with a single healthcare-focused institutional invest...
Gainers: Elevation Oncology (ELEV) +20%. Cue Biopharma (CUE) +14%. Evelo Biosciences (EVLO) +13%. GeoVax Labs (GOVX) +13%. Immix Biopharma (IMMX) +9%. Losers: Verrica Pharmaceuticals (VRCA) -58%. PMV Pharmaceuticals (PMVP) -10%. TransMedics (TMDX) ...
Best Penny Stocks to Watch During Trading This Week After another interesting day of trading penny stocks and blue chips, there is a lot for investors to know. Right now, we have several factors that are causing movement with penny stocks . And all of this has caused another day of ...
News, Short Squeeze, Breakout and More Instantly...
ATLANTA, GA - ( NewMediaWire ) - July 11, 2024 - GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing immunotherapies and vaccines against cancer and infectious diseases, today announced that it has entered into a definitive securities purchase agreement with a cert...
GeoVax Labs, Inc. (NASDAQ: GOVX) is one of today's top gainers. The company's shares have moved 20.05% on the day to $3.02. GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using modified vaccinia ank...
Award of BARDA Project NextGen contract represents a significant milestone event; total value of award to GeoVax and its CRO partner total approximately $367-388 million BARDA-funded 10,000-participant Phase 2b study will evaluate and compare GeoVax’s ...